Monique da Silva

Nessuna posizione attualmente

Health Technology

Commercial Services

Consumer Services

Profilo

Monique da Silva worked at Ogilvy Public Relations Worldwide, Inc. as EVP & Head-North America Healthcare Practice.
Worked at Spark Therapeutics, Inc. as Vice President-Corporate Communications from 2016 to 2020.
Worked at AVROBIO, Inc. as Senior Vice President-Corporate Communications.
Worked at AnaptysBio, Inc. as Senior Vice President-Corporate Affairs.
Completed undergraduate education at Bowdoin College.

Precedenti posizioni note di Monique da Silva

Società	Posizione	Fine
ANAPTYSBIO, INC.	Corporate Officer/Principal	01/04/2026
SPARK THERAPEUTICS, INC.	Public Communications Contact	01/01/2020
TECTONIC THERAPEUTIC, INC.	Public Communications Contact	-
Ogilvy Public Relations Worldwide, Inc. Ogilvy Public Relations Worldwide, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations and marketing solutions	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Monique da Silva

Formazione di Monique da Silva

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Monique da Silva

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	5
AnaptysBio, Inc. AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company	Health Technology
Ogilvy Public Relations Worldwide, Inc. Ogilvy Public Relations Worldwide, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations and marketing solutions	Commercial Services
Bowdoin College Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spark Therapeutics, Inc. Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases	Health Technology
AVROBIO, Inc. AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose	Health Technology